Bikam Pharmaceuticals

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Ikarovec

This company develops bicistronic gene therapies to treat chronic ophthalmic diseases, such as age-related macular degeneration, for patients suffering from vision loss.

Roca Therapeutics

The company develops small molecule therapies for patients with severe ocular diseases and cancers such as uveal melanoma.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Restore Vision

This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.

Alkeus Pharmaceuticals

This biopharmaceutical company develops oral therapies to prevent vision loss for patients suffering from Stargardt disease and geographic atrophy.

Fovea

This company develops biopharmaceutical drugs to treat ocular diseases and retinal pathologies for patients with disabling eye conditions.